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Macquarie Private Hospital, Newcastle, NSW, AustraliaIntroduction. The aim of this study was to review our experience of popliteal aneurysms using endovascular techniques.
Methods. Thirty popliteal aneurysms in 25 patients were treated over an 11-year period. Median aneurysm diameter was 26
(16–48) mm. Five were symptomatic and 25 asymptomatic. Patients were treated with the Haemobahn/Viabahn stent-graft
(26), Passager (two), Aneurx (one), and PTFE homemade device (one). Data were assessed using life table analysis, and
expressed as cumulative patency rates and standard error (SE).
Results. Median follow-up was 24 (range 1–95) months. Primary patency was 92.9% (SE 4.5%), 84.7% (SE 6.8%), 80%
(SE 8.2%), 74.5% (SE 9.4%) and 74.5% (11.3%) at 1, 6, 12, 24 and 36 months, respectively. Cumulative secondary patency
was 96.5% (SE 3.3%), 88.7% (SE 6.0%), 88.7% (SE 8.6%), 83.2% (SE 8.0%) and 83.2% (SE 9.8%) at 1, 6, 12, 24 and 36
months, respectively.
Conclusion. Endovascular treatment of popliteal aneurysms in this series achieved patency rates similar to open surgery.
Aneurysm repair was performed without peroperative deaths and the risks associated with open surgery.Keywords: Popliteal aneurysms; Limb loss; Flexible stent grafts; Thrombolysis; Patency rates; Antiplatelet agents; Endoleak.Introduction
Popliteal aneurysms (PA) may cause serious ischaemic
complications, associated with thrombosis or emboli-
sation, resulting in limb loss. Popliteal aneurysms are
associated with nerve and vein compression and also
rupture and death. Guvendik et al. described PA as the
‘sinister harbinger of sudden catastrophe’.1 PA has a
prevalence of 1% in the general population, is often
bilateral, and associated with abdominal aortic aneur-
ysms.2,3 It is estimated that the likelihood of an
asymptomatic popliteal aneurysm becoming sympto-
matic is around 14–24% per year.2,4 Untreated PA will
progress to complications in almost 70% of cases in 5
years and has a strong association with limb loss in up
to 30–40% of patients.2,4
Antyllus in 200 BC first described ligation and
packing as the treatment of popliteal aneurysm.5 Since
then, the traditional method of treating PA has beent the European Society for Vascular Surgery, XIX
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polytetrafluoroethylene (PTFE) as the conduit, from a
medial or posterior surgical approach. These pro-
cedures have patency rates of 70–80% at 5 years for
vein grafts and much less for prosthetics.4,6,7 Saphe-
nous vein has, therefore, remained the conduit of
choice. There is some controversy as to what
constitutes the threshold size for intervention for
asymptomatic PAs. Lowell and colleagues, rec-
ommended surgery for PAs greater than 2 cm, but
Galland recommended 3 cm as a cut-off.8,9 All,
however, agree that PAs more than 3 cm require
intervention, and many authors have noted that
outcome is better with elective intervention before
loss of distal runoff vessels from embolisation.8,10
The advent of endovascular technology and its
application in the treatment of aortic aneurysms, have
led to the adaptation of these techniques for the
treatment of peripheral aneurysms. The first case was
reported by Marin et al. using a home made device.11
Since then, there have been many advances in the
design and types of stent grafts, including the highly
flexible PTFE lined nitinol stents (W.L. Gore and
Associates, Inc., Flagstaff, AZ, USA). These stents areEur J Vasc Endovasc Surg 32, 149–154 (2006)
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mechanical stresses that are observed in the popliteal
artery. This retrospective study reviewed our experi-
ence of treating popliteal aneurysms using endovas-
cular techniques.Table 2. Vascular characteristics of patients and limbs treated with
popliteal endografts
Popliteal aneurysms
Median popliteal aneurysm
diameters
26 (range 16–48) mm
Symptomatic 5
Asymptomatic 25
n
Runoff vessels
0 1
1 8Methods
Thirty PA in 25 patients were treated over an 11-year
period (1994–2005) at two centres. All patients were
male and the median age was 74 (range 56–83) years.
Patient risk factors are shown in Table 1. All patients
had colour flow duplex and angiography, and ankle
brachial pressure index (ABPI) measured pre-opera-
tively, 18 limbs were also investigated with spiral CT
(computerized tomography) scans.
The popliteal artery was considered aneurysmal if it
was more than 2.0 cm in diameter, or was 1.5 times the
diameter of the adjacent normal popliteal artery. The
smallest aneurysms treated were 16 mm diameter (in
two patients); one was symptomatic and the other
patient had had his contralateral PA previously
treated, and requested intervention. Five limbs were
symptomatic, one with acute ischaemia, treated with
thrombolysis prior to stenting of the popliteal aneur-
ysm. One patient had limiting claudication, one
presented with venous compression, and one had
symptoms of embolisation. A further nine patients had
mild to moderate claudication reflecting the number of
run-off vessels (ABPI!0.8). All but one patient in this
series had atherosclerotic popliteal aneurysms: this
patient had a false aneurysm, following a knee injury
12 months previously. One patient developed true
aneurysms in the popliteal arteries bilaterally, after
femoro-popliteal bypass surgery for claudication (22
and 28 years previously). Aneurysm characteristics are
shown in Table 2.
All procedures were performed in the main
operating theatre. Interventions were carried out
under local anaesthesia in 22 limbs, regional anaes-
thesia in four, and general anaesthesia in four. Two
patients had bilateral procedures at the same sitting.
Heparin and an antiplatelet agents were given in all
cases. All cases were approached from an ipsilateralTable 1. Vascular risk factors for patients with popliteal aneurysms
Risk factors n Percentage
Hypertension 22 88
Hypercholesterolaemia 10 40
History of smoking 21 84
Ischaemic heart disease 10 40
Diabetes 2 8
Chronic bronchitis 8 32
Eur J Vasc Endovasc Surg Vol 32, August 2006antegrade common femoral artery puncture with an 8–
14 Fr sheath. Twenty-six limbs were treated with the
Haemobahn/Viabahn stent graft (W.L. Gore and
Associates, Inc., Flagstaff, AZ, USA). We also used
Passager (two) (Boston Scientific, Waterdown, MA,
USA); Aneurx (one) (Medtronic, Inc., Minneapolis,
MN, USA); and a PTFE homemade device (one).
One patient who developed popliteal aneurysms
following femoro-popliteal bypass grafts in the 1970s
for claudication, had cut-down procedures to the vein
grafts through which the stent grafts were deployed,
the first was repaired in 1996 with a Passager stent
graft (Boston Scientific, Waterdown, MA, USA), and
the contralateral side in 2002 with an Aneurx stent
graft (Medtronic, Inc., Minneapolis, MN, USA). One
further Passager graft was deployed in 1998, all other
patients had Haemobahn/Viabahn stent grafts (W.L.
Gore and Associates, Inc., Flagstaff, AZ, USA)
(Fig. 1(a)–(d)).
Inclusion criteria used in patient selection for
endovascular treatment of PA were anatomical suit-
ability for use of an endovascular device, including
non-aneurysmal or stenotic access vessels; suitable
healthy vessels (at least 2.0 cm in length) for proximal
and distal fixation of the endovascular device, in
addition we were very cautious with extensive
tortuous aneurysms and the possible need for
numerous stents. Overall 50% of popliteal aneurysms
treated at our two centres during this time period were
treated with stent grafts; all others had open surgery
for symptoms or unsuitable anatomy.
Stent-graft sizing was determined by duplex and
calibrated angiography with at least 1 mm oversize.
Completion angiogram and post-operative Duplex2 14
3 7
Contralateral popliteal artery
Normal 9
Aneurysmal 13
Occluded 3
Previous bypass 2
Ectatic 3
Abdominal aorta
Aneurysmal 11
Non-aneurysmal 14
Fig. 1. (a) Preliminary arteriogram for calibration and sizing a popliteal aneurysm for stenting. (b) Radiograph demonstrating
positioning of the stent graft device for popliteal aneurysm stenting. (c) Angiogram after deployment of Haemobahn stent
graft excluding the popliteal aneurysm. (d) Lateral view angiogram of the popliteal artery aneurysm after deployment of the
stent graft with the knee in the 908-flexed position.
Endovascular Popliteal Aneurysm Repair 151was performed in all cases, together with a lateral view
with the knee in the flexed position. All patients had
duplex scans at 1 month, 3 months and then at
6-monthly intervals. All patients were given antiplate-
let agents in the long term, this was initially aspirin
and more recently some patients were prescribed
clopidogrel. Descriptive statistics were used and data
were assessed using Kaplan–Meier life table analysis,
and expressed as cumulative patency rates and
standard error (SE).12Results
Deployment was successful in all 30 cases and there
were no early mortality. Median follow up was 24
(range 1–95) months, and there was no limb loss.
Median number of stents used was 2 (range 1–3).
Where multiple stents were used, we aimed for at least2 cm overlap or more. Median aneurysm length was 10
(range 6–24) cm and median covered length with the
endograft was 15 (range 10–30) cm, the distal popliteal
artery was the landing site in all cases apart from two;
in these the landing zone was in the tibio-peroneal
trunk. In only one of these two were the anterior tibial
artery sacrificed, as it was previously occluded in the
other.
Our earliest popliteal aneurysm was repaired in
1994 with a homemade PTFE device (similar to that
used by Marin),11 this graft occluded after 4 months;
but the limb was salvaged with an in situ femoro-
peroneal vein graft. Another graft occlusion occurred
at 10 months, which was successfully thrombolysed,
proximal extension of the aneurysm was noted and
restented, the graft itself had not migrated. One graft
failure occurred at 2 months following a period of
prolonged knee flexion (thrombolysis was unsuccess-
ful), and another after 19 months when the patientsEur J Vasc Endovasc Surg Vol 32, August 2006
Table 3. Summary of outcome for failed popliteal endografts
Age (years) Time to occlusion Graft type Treatment Secondary patency Outcome
68 10 days Haemobahn Femoro-peroneal bypass No Limb salvage
83 1 month Haemobahn Successful thrombolysis 20 months Limb salvage
73 2 months Haemobahn Failed thrombolysis No Claudication
59 4 months PTFE Femoro-peroneal bypass No Limb salvage
70 10 months Haemobahn Successful thrombolysis 47 months Limb salvage
82 19 months Haemobahn None No Claudication
I. V. Mohan et al.152developed cardiac failure. Two further graft failures
are described in Table 3. None of our patients with
failed grafts had amputations, two had successful
thrombolysis, two had successful limb salvage surgery
(femoro-peroneal bypass grafts) and two became
claudicants (ABPI 0.5–0.6) and declined further
intervention (Table 3).
Three endoleaks were noted altogether; two type II
endoleaks, one observed early and resolved spon-
taneously, and the other a late observation that is still
being monitored. There was a small distal type I
endoleak which resolved spontaneously after 1 month.
Two patients in this series died during follow-up, one
at 6 months from a myocardial infarction and the other
from heart failure at 20 months. The second patient
occluded his endograft 1 month prior to his death
(after 19 months). Overall mean aneurysm diameter
decreased by 0.4 (range 0–1.2) cm and no sacPopliteal Aneurysm 
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Eur J Vasc Endovasc Surg Vol 32, August 2006enlargement was noted, even in the patients with
endoleak. Stent graft migration was not observed in
this study.
Overall 1-month cumulative primary patency was
92.9% (SE 4.5%). Six-month primary cumulative
patency was 84.7% (SE 6.8%), and 12-month patency
was 80% (SE 8.2%). Cumulative primary patency
remains at 74.5% at 24 and 36 months (SE 9.4 and
11.3%, respectively). Cumulative one-month second-
ary patency was 96.9% (SE 3.3%), 88.7% at 6 and 12
months (SE 6.0 and 6.7%), and 83.2% at 24 and 36
months (SE 8.0 and 9.8%) (Fig. 2).Discussion
This study is the second largest series of endovascular
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Endovascular Popliteal Aneurysm Repair 153are consistent with the experience of the Groningen
group who presented data on 57 unselected patients
treated with the Haemobahn/Viabahn stent graft
alone.13 Two of our six occlusions (33%) occurred
within the 1st month, and four (66%) occurred within
the first 4 months; and there were two late occlusions
(at 10 and 19 months). Primary cumulative patency
rates were 80% at 12 months, and 74.5% at 24 and 36
months; cumulative secondary patency rates were
88.7% at 12 months, and 83.2% at 24 and 36 months.
Conventional bypass grafting has achieved average
5-year graft patency of between 70 and 80%.3,4,7 The
outcome for symptomatic patients is worse than that
for asymptomatic patients and also for patients with
fewer runoff vessels, and early intervention in
popliteal aneurysms may avoid the degradation of
runoff vessels.10,14 Because of small numbers in
currently published series, we cannot yet show that
the same result, for graft patency, will hold true for
endovascularly treated popliteal aneurysms in the
long term. However, significant progress has been
made since our first endograft repair of a popliteal
aneurysm was attempted in 1994, with a polytetra-
fluoroethylene (PTFE) graft, similar to that described
by Marin and colleagues.11 We used the Passager stent
graft in two patients (Boston Scientific, Waterdown,
MA, USA), and the limb of an Aneurx (Medtronic, Inc.,
Minneapolis, MN, USA) aortic stent graft in another.
These grafts were not very compliant or flexible, and
probably not well suited for use in the highly mobile
popliteal vessels, but remained patent at more than 30
months of follow-up. Since then, there has been
increasing availability and refinement of commercially
available stent grafts, especially the highly flexible,
Haemobahn/Viabahn nitinol stent graft (W.L. Gore
and Associates, Inc., Flagstaff, AZ, USA).
The biomechanical forces that influence the popli-
teal artery during movement appear to be unique in
the human body. Wensing and colleagues described
dynamic changes in curvature of the femoro-popliteal
segment corresponding to the patient’s age.15 They
concluded that in the flexed position in patients under
30 years of age, minor arterial curves were noted
proximal to the adductor hiatus. In patients over 45
years one or more curves were located distal to the
adductor hiatus (in the popliteal fossa). And in
patients over the age of 60 years, the curves did not
disappear during knee extension. For this and other
reasons, all of our recent experience has been with the
Haemobahn/Viabahn stent graft; this self-expanding
graft (sinusoidally shaped, helically wrapped) with
ultrathin (100 mm) ePTFE coating luminal surface is
flexible, relatively kink resistant and seems best for
placement in the popliteal artery. Haemobahndeployment is different from Viabahn, Haemobahn
unfolds from a rolled/furled configuration and may
not open fully if there is significant oversizing. This
can be difficult to detect since balloon dilatation inside
the graft does not necessarily show the infolding,
which is dependent on angle of the image intensifier
tube. Viabahn is packed in a more favorable way, with
concentric multiple minor folds.
There are some limitations with the Haemobahn/-
Viabahn stent graft. It can shorten significantly, and
may also ‘bow’ into a larger sac, causing uncertainty of
position, and sometimes make it necessary to use
several grafts overlapped. It may be difficult to use if
there is not a good ‘neck’ or cuff of relatively normal
popliteal artery distally (especially if it shortens).
Extensive, tortuous popliteal aneurysms are probably
not good candidates for endovascular repair due to
tortuosity and compression of the grafts and the
requirement for multiple overlapping segments.
Diaz and colleagues further investigated the
morphological changes in the popliteal artery during
knee flexion and described the presence of ‘hinge
points’ in this vessel segment.16 Biomechanical
stresses between the host artery and the implanted
stent as a result of this mobility may be responsible for
stent fractures. The debate regarding stent fractures
has significant implications after the insertion of a
stent graft in relation to occlusion. The SIROCCO I trial
was designed to investigate the effectiveness of self
expanding, drug-eluting stents in the treatment of
femoro-popliteal occlusive disease; this study demon-
strated a stent fracture rate of 18.2% in patients with
multiple stents in the femoro-popliteal segment, but
did not find any correlation with graft occlusion.17
Scheinert and colleagues, however, reported a stent
fracture rate of 37.2% in the femoro-popliteal segment
and demonstrated a reocclusion rate of 34.4% in limbs
with fractured stents.18 Tielliu, reporting the largest
series of endograft repair of popliteal aneurysms,
found two stent fractures in the Haemobahn device
that ultimately resulted in graft occlusions.13 One of
the limitations of this series is that our cohort did not
all have plain radiographs in follow-up and we cannot
comment on stent fractures.
All of our patients were placed on antiplatelet
therapy, aspirin (75–325 mg) and more recently we
have used clopidogrel (75 mg); two of our patients
were also on warfarin for atrial fibrillation. This
rationale is based on the Antiplatelet Trialists’
Collaboration that demonstrated a 32% reduction in
graft occlusion in patients who received antiplatelet
agents.19 The CAPRIE Trial subsequently demon-
strated an increased benefit of clopidogrel over
aspirin.20 The CREDO trial found that a loadingEur J Vasc Endovasc Surg Vol 32, August 2006
I. V. Mohan et al.154strategy and long term clopidogrel therapy signifi-
cantly reduced death and vascular events for coronary
stents.21 Although the benefits of antiplatelet agents
are well established, there are no specific data
supporting the use of antiplatelet agents in the lower
limbs, either as monotherapy or as combination
therapy. However, in a univariate analysis, the
Groningen group found that the additional use of
clopidogrel was the only factor that predicted success
of a popliteal stent graft.13
Endovascular repair of abdominal aortic aneurysm
is associated with types I and II endoleaks, and we
have described similar findings after endovascular
repair of the popliteal artery. Thus far, we have noted
no evidence of enlargement of the aneurysm sac.
Whether or not this will feature in the long term is yet
to be determined, but we do know that popliteal
aneurysms treated by exclusion and bypass may
demonstrate persistent blood flow and even enlarge-
ment of the aneurysm sac.22,23
The advent of flexible and versatile new stent grafts
marks a major step forward in the treatment of
popliteal (and perhaps other peripheral) aneurysms
with results comparable to conventional surgery.13,24
Endovascular repair of popliteal aneurysms is a
promising technique with good short and intermedi-
ate term results. However, long term surveillance of
these procedures in essential to monitor the function
and durability of the stent grafts. Antiplatelet therapy
in the form of clopidogrel as monotherapy or
combination therapy is essential.13,25
In conclusion, endovascular treatment of popliteal
aneurysms in this selected series of patients with
suitable anatomy achieved patency rates similar to
that of open surgery. Aneurysm repair was performed
without peroperative deaths, and endograft failure in
this series was not associated with limb loss.References
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